German drug and development company Evotec (EVTG.DE) has entered into a technology development partnership with Novo Nordisk (NOVOb.CO) to support clinical and commercial manufacturing of stem cell-based therapies, Evotec said on Thursday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,